Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0002092017-25-000003
Filing Date
2025-11-05
Accepted
2025-11-05 20:09:19
Documents
2
Period of Report
2025-11-05

Document Format Files

Seq Description Document Type Size
1 form3-11062025_011115.html 3  
1 form3-11062025_011115.xml 3 11446
2 ex24-11062025_011117.htm EX-24 6253
  Complete submission text file 0002092017-25-000003.txt   19073
Mailing Address 1841 PAGE MILL RD PALO ALTO CA 94304
Business Address 1841 PAGE MILL RD PALO ALTO CA 94304 (650) 223-7745
Evommune, Inc. (Issuer) CIK: 0002044725 (see all company filings)

EIN.: 850742575 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1841 PAGE MILL ROAD, SUITE 100 PALO ALTO CA 94304
Business Address
Patel Jeegar Pravinkumar (Reporting) CIK: 0002092017 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-42938 | Film No.: 251455664